4basebio announces strategic collaboration with Genezen
Inify Laboratories launches UK operations with first NHS agreement
Senhwa completes enrolment in Phase 1b expansion trial of CX-5461
Annovis Bio schedules corporate update webinar for next week
McKesson to acquire Precision Medicine Group for approximately USD2.25bn
CDT signs SAFE note with Pep'd to expand US peptide market exposure
Astellas doses first patient in Phase 3 study of ASP2138
Antengene's Phase I study of ATG-201 in B cell-related autoimmune diseases approved in Australia
United Therapeutics wins FDA acceptance for ralinepag PAH filing
Takeda wins Japan approval for ORZEYFUL to treat underlying cause of narcolepsy type 1
Acadia wins EU approval for DAYBU as first treatment for Rett syndrome
Gilead expands Trodelvy role in first-line metastatic triple-negative breast cancer in Europe
GSK's Jemperli wins FDA priority review for advanced rectal cancer